TransMedics Group, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Shareholders held by TransMedics Group, Inc. on May 22, 2025. The filing details the results of shareholder votes on director elections, executive compensation, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Shareholders voted on three proposals at the Annual Meeting:
- Proposal One (Director Elections): All eight nominees were elected to the Board of Directors for terms ending at the 2026 Annual Meeting. Notable vote counts included:
| Director Nominee | For Votes | Against Votes | Abstain |
|---|---|---|---|
| Waleed Hassanein, M.D. | 21,530,830 | 124,816 | 38,595 |
| James R. Tobin | 21,154,414 | 491,441 | 48,386 |
| Edward M. Basile | 19,518,021 | 2,128,247 | 47,973 |
| Thomas J. Gunderson | 21,367,800 | 277,962 | 48,479 |
| Edwin M. Kania, Jr. | 19,583,104 | 2,062,278 | 48,859 |
| Stephanie Lovell | 21,338,519 | 305,597 | 50,125 |
| Merilee Raines | 21,421,630 | 224,815 | 47,796 |
| David Weill, M.D. | 21,250,720 | 395,207 | 48,314 |
- Proposal Two (Say-on-Pay): Shareholders approved the compensation of named executive officers on a non-binding advisory basis with 20,883,760 votes For, 755,962 Against, and 54,519 Abstain.
- Proposal Three (Auditor Ratification): Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with 24,433,217 votes For, 2,147,182 Against, and 53,006 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of votes cast against specific directors, particularly Edward M. Basile and Edwin M. Kania, Jr., who received over 2 million "Against" votes.
- Confirm the term expiration dates for the newly elected directors (2026 Annual Meeting).
- Review the full proxy statement for details on the specific compensation packages approved in Proposal Two.
- Note the significant number of Broker Non-Votes (4,939,164) recorded for all proposals, indicating shares held by brokers that were not voted on these matters.